Trans-3′-hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking

British Journal of Clinical Pharmacology

Volumn 51, Issue 1, 2001, Pages 53-59

  Benowitz, N L ^a,b   Jacob III, P ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 hydroxycotinine; Cotinine; Metabolism; Nicotine; Pharma cokinetics; Pharmacodynamics; Smoking; Tobacco

Indexed keywords

3' HYDROXYCOTININE; 3' HYDROXYCOTININE GLUCURONIDE; COTININE; NICOTINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; HYDROXYCOTININE;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CIGARETTE SMOKING; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFECT; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; TOBACCO; URINE LEVEL; AFFECT; BLOOD; CLINICAL TRIAL; HALF LIFE TIME; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; SMOKING; TISSUE DISTRIBUTION;

ADULT; AFFECT; COTININE; FEMALE; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NICOTINE; SMOKING; TISSUE DISTRIBUTION;

EID: 0034746463     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.01309.x     Document Type: Article

References (26)

1. Importance of nicotine metabolism in understanding the human biology of nicotine
2. Metabolism of nicotine to cotinine studied by a dual stable isotope method
3. Enantiomeric purity of nicotine in tobacco smoke condensate
4. A study of the optical activity of smoke nicotines
5. Enantiomeric composition of nicotine in smokeless tobacco, medicinal products, and commercial reagents
6. The synthesis of hydroxycotinine and studies on its structure
7. Structure of hydroxycotinine, a nicotine metabolite
8. Trans-3′-hydroxycotinine as a main metabolite in urine of smokers
9. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers
10. Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine
11. Synthesis of (3′R,5′S)-trans-3′-hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3′-hydroxycotinine in humans is highly stereoselective
12. Identification of cis-3′-hydroxycotinine as a urinary nicotine metabolite
13. Nicotine phase 2 metabolites in human urine - Structure of metabolically formed trans-3′-hydroxycotinine glucuronide
14. Pharmacokinetics of nicotine, cotinine, and 3′-hydroxycotinine in cigarette smokers
15. Cotinine disposition and effects
16. Studies on the metabolism of (-)-cotinine in the human
17. Determination of the nicotine metabolite trans-3′-hydroxycotinine in smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring
18. Noncompartmental determination of the steady state volume of distribution
19. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking
20. Gas chromatographic determination of trans-3′-hydroxycotinine, a major metabolite of nicotine in smokers
21. Simultaneous determination of cotinine and trans-3′-hydroxycotinine in human serum by high-performance liquid chromatography
22. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes
23. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes
24. Role of human cytochrome P4502A6 in C-oxidation of nicotine